ENDRA LIFE SCIENCES INC. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ENDRA LIFE SCIENCES INC. stock issued during period, shares, new issues for the quarter ending 2025-06-30 was 190.18K shares.
- ENDRA LIFE SCIENCES INC. stock issued during period, shares, new issues for the quarter ending 2025-03-31 was 25.30K shares.
- ENDRA LIFE SCIENCES INC. stock issued during period, shares, new issues for fiscal 2019 was 375.52K shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2025-06-30 | 190.18K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | |
| 2025-03-31 | 25.30K shares 10-Q · filed 2025-05-15 | |
| 2019-12-31 | 375.52K shares 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |